Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Cyclospora parasite illnesses have affected 28 NC counties, sickened more than 200 people
Recommended
UNC has a new chancellor. Why interim Lee Roberts got the permanent job.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here
September 21, 2023
Tickers
ENVB
Tags
News
Penny Stocks
USPTO
From
Benzinga
Healthcare Providers Can Offer Ketamine Treatment On Employee Insurance Plans
September 20, 2023
Tags
Benzinga
Psychedelics
Ketamine/Assisted Therapy
From
Benzinga
Congress To Discuss New Bill Banning Federal Intervention In States Where Psilocybin Is Legal
September 20, 2023
Tags
Psychedelics Reform
Psychedelic/Assisted Therapies
General
From
Benzinga
Kentucky's $42M Ibogaine Budget Plan For Opioid Crisis Hears Testimonies At Second Meeting
September 19, 2023
Tags
Psychedelics
Benzinga
News
From
Benzinga
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
September 18, 2023
Tickers
ATAI
CMND
CMPS
DRUG
Tags
ATAI
News
SILO
From
Benzinga
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
September 18, 2023
Tickers
MSSTF
Tags
MSSTF
Guidance
News
From
Benzinga
Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update
September 18, 2023
Tickers
ATAI
CYBN
DMTTF
MNMD
Tags
Steve Cohen
Cannabis
Market News
From
Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Tickers
NUMIF
Tags
Market News
Cannabis
Markets
From
Benzinga
Combining MDMA With Psilocybin Or LSD Could Reduce Difficult Trips, New Study Shows
September 13, 2023
Tickers
MNMD
Tags
News
Penny Stocks
Market News
From
Benzinga
Swedish Foundation Supports Mental Health Innovation With New €3M Psychedelic Science Initiative
September 13, 2023
Tickers
CMPS
Tags
Norrsken Foundation
Psychedelic/Assisted Therapies
CMPS
From
Benzinga
Congress Update: House Committee Green Lights Psychedelics Amendments
September 13, 2023
Tags
Federal spending Bill
Government
Psychedelics
From
Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
Tickers
ATAI
CMPS
CYBN
JAZZ
Tags
SILO
Penny Stocks
ATAI
From
Benzinga
Michigan Resolution: Veterans Across US Should Have Access To Psychedelic-Assisted Therapy
September 08, 2023
Tags
Benzinga
Psychedelics
military veterans
From
Benzinga
'Wolf Of Wall Street' Embraces Ibogaine For Addiction Recovery With Help Of 'Psychedelic Concierge'
September 08, 2023
Tags
Global
Cannabis
Market News
From
Benzinga
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
September 08, 2023
Tickers
OPTHF
Tags
Benzinga
Psychedelics
Management
From
Benzinga
Shaping Federal Policy Around Psychedelic Therapy: APPA Teams Up With Daschle Group
September 07, 2023
Tags
Markets
the FDA
Market News
From
Benzinga
Psychedelics Reform Update: CA Bill's Final Vote, MA 2024 Legalization Ballot, HI Task Force, OR Funding And More
September 07, 2023
Tags
Psychedelic/Assisted Therapies
Market News
Cannabis
From
Benzinga
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program
September 06, 2023
Tickers
CMND
Tags
Cannabis
Johns Hopkins University
Market News
From
Benzinga
PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application
September 06, 2023
Tickers
PHRRF
Tags
PHRRF
Psychedelic/Assisted Therapies
FDA
From
Benzinga
Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression
September 06, 2023
Tickers
CMPS
Tags
Rumors
Psychedelic/Assisted Therapies
CMPS
From
Benzinga
Cybin's Intellectual Powerhouse Grows With New US Patent Covering Deuterated 5-MeO-DMT
September 05, 2023
Tickers
CYBN
DMTTF
Tags
Benzinga
Psychedelics
Tryptamines
From
Benzinga
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
Tickers
ATAI
BRAXF
CMPS
CYBN
Tags
Market News
SEEL
ENVB
From
Benzinga
Sacred Medicine Meets Wall Street: Legal Peyote Company Will Trade On Canadian Market
September 04, 2023
Tags
Psychedelics
Benzinga
Lophos Holdings Inc/
From
Benzinga
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows
September 03, 2023
Tags
Psychedelics
Benzinga
Psilocybin program
From
Benzinga
Pete Davidson Reveals He's Tried Ketamine To Cope With Depression
September 01, 2023
Tickers
JNJ
Tags
depression treatment
Psychedelic/Assisted Therapies
Benzinga
From
Benzinga
UK Psychedelics Update: MPs Seek Rescheduling, Safe Consumption Sites, OD Prevention Fund
September 01, 2023
Tickers
UK
Tags
drug reform
UK
Guidance
From
Benzinga
Colorado's Psychedelic Future Unfolds: Regulators Host Community Meetings To Shape Industry Rules
August 31, 2023
Tags
Psychedelic/Assisted Therapies
Markets
Cannabis
From
Benzinga
Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions
August 31, 2023
Tickers
CYBN
DMTTF
MSSTF
NUGL
Tags
CYBN
Otsuka Pharmaceutical Co
Psychedelic/Assisted Therapies
From
Benzinga
Braxia Scientific Faces Challenges In Accessing Public Market Capital, Reports Q1 Loss
August 31, 2023
Tickers
BRAXF
Tags
Markets
Cannabis
Market News
From
Benzinga
Red Light Holland's Q1 2024 Performance: Revenue Soars 53% And Solid Cash Balance
August 29, 2023
Tickers
TRUFF
Tags
Penny Stocks
Earnings
News
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.